BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8882 related articles for article (PubMed ID: 10630072)

  • 1. [Anatomo-pathologic study of sentinel lymph nodes in melanoma. Analysis of 200 cases].
    Riccioni L; Morigi F; Naldi S; Polverelli M; Morelli R; Fiscelli O; Landi G; Giangaspero F
    Pathologica; 1999 Aug; 91(4):242-8. PubMed ID: 10630072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
    Morton DL; Hoon DS; Cochran AJ; Turner RR; Essner R; Takeuchi H; Wanek LA; Glass E; Foshag LJ; Hsueh EC; Bilchik AJ; Elashoff D; Elashoff R
    Ann Surg; 2003 Oct; 238(4):538-49; discussion 549-50. PubMed ID: 14530725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local lymph node micrometastasis in a patient with negative sentinel lymph node biopsies after lymphatic mapping with wide local excision of primary melanoma on the head/neck area.
    Querfeld C; Wayne JD; Wei JJ; Abdul-Nabi A; Gerami P
    Am J Dermatopathol; 2011 Oct; 33(7):745-8. PubMed ID: 21946765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The argument against sentinel node biopsy for malignant melanoma.
    Thomas JM; Patocskai EJ
    BMJ; 2000 Jul; 321(7252):3-4. PubMed ID: 10875809
    [No Abstract]   [Full Text] [Related]  

  • 5. Photothermal multispectral image cytometry for quantitative histology of nanoparticles and micrometastasis in intact, stained and selectively burned tissues.
    Nedosekin DA; Shashkov EV; Galanzha EI; Hennings L; Zharov VP
    Cytometry A; 2010 Nov; 77(11):1049-58. PubMed ID: 20949577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wide Local Excision Before Sentinel Lymph Node Biopsy in Melanoma.
    Tassavor M; Bland M; Goldenberg O; Tassavor B; Coldiron B
    Dermatol Surg; 2024 May; ():. PubMed ID: 38810277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in melanoma epidemiology, 1993.
    Elwood JM
    Melanoma Res; 1993 Jun; 3(3):149-56. PubMed ID: 8400852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography in diagnosing, differentiating and monitoring of choroidal nevi - 1 year observational study.
    Golebiewska J; Kecik D; Turczynska M; Ciszewska J; Moneta-Wielgos J; Pihowicz-Bakon K
    Neuro Endocrinol Lett; 2013; 34(6):539-42. PubMed ID: 24378457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.
    Feun L; Marini A; Moffat F; Savaraj N; Hurley J; Mazumder A
    Cancer Invest; 2005; 23(1):3-8. PubMed ID: 15779861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a melanin-producing cell line derived from a canine malignant melanoma.
    Inoue M; Yamate J; Sato A
    Nihon Juigaku Zasshi; 1980 Dec; 42(6):695-702. PubMed ID: 7230575
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromodeoxyuridine treatment of melanoma cells decreases rubidium transport.
    Evans I; Kung LS; Bosmann HB; Banerjee SP
    Cell Biol Int Rep; 1978 Mar; 2(2):195-8. PubMed ID: 566630
    [No Abstract]   [Full Text] [Related]  

  • 13. Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities.
    Nakae K; Yoshimoto Y; Sawa T; Homma Y; Hamada M; Takeuchi T; Imoto M
    J Antibiot (Tokyo); 2000 Oct; 53(10):1130-6. PubMed ID: 11132958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assays for mammalian tyrosinase: a comparative study.
    Jara JR; Solano F; Lozano JA
    Pigment Cell Res; 1988; 1(5):332-9. PubMed ID: 2907130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.
    Wahl RL; Swanson NA; Johnson JW; Natale R; Petry NA; Mallette S; Kasina S; Reno J; Sullivan K; Abrams P
    Am J Physiol Imaging; 1992; 7(2):48-58. PubMed ID: 1419120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antitumour activity of orsellinates.
    Bogo D; de Matos MF; Honda NK; Pontes EC; Oguma PM; da Santos EC; de Carvalho JE; Nomizo A
    Z Naturforsch C J Biosci; 2010; 65(1-2):43-8. PubMed ID: 20355320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).
    Freeman KP; Hahn KA; Harris FD; King GK
    J Vet Intern Med; 2003; 17(1):96-101. PubMed ID: 12564733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors.
    Zhang T; Tsang TC; Harris DT
    Biotechniques; 2002 Nov; 33(5):1146-51. PubMed ID: 12449396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol and radiation.
    Geard CR; Jones JM; Schiff PB
    J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-gene-modified tumor vaccination intensified by a streptococcal preparation OK-432.
    Abe J; Wakimoto H; Aoyagi M; Hirakawa K; Hamada H
    Cancer Immunol Immunother; 1995 Aug; 41(2):82-6. PubMed ID: 7656273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 445.